Merck is working with a diagnostic company , NanoString Technologies , to develop a test that measures activity levels in genes associated with immune response .
默克正在与诊断技术公司“奈米序列科技(NanoStringTechnologies)合作,研发一种测试,用以测量与免疫反应相关的基因的活跃程度。